| Literature DB >> 3553249 |
Abstract
There is strong evidence linking Kaposi's sarcoma with an increased risk of developing a second primary malignancy. This risk of a second malignancy appears to depend in part on the clinical setting in which Kaposi's sarcoma develops. This paper examines these risks by relating them to specific subsets of Kaposi's sarcoma and to specific types of second malignancies.Entities:
Mesh:
Substances:
Year: 1987 PMID: 3553249 DOI: 10.1016/s0190-9622(87)70112-1
Source DB: PubMed Journal: J Am Acad Dermatol ISSN: 0190-9622 Impact factor: 11.527